Search

HHS Statements on Authorizing Licensed Pharmacists to Order and Administer COVID-19 Tests

In an effort to expand testing capabilities, HHS is authorizing licensed pharmacists to order and administer COVID-19 tests to their patients. The accessibility and distribution of retail and independent community-based pharmacies make pharmacists the first point of contact with a healthcare professional for many Americans. This will further expand testing for Americans, particularly our healthcare workers and first responders who are working around the clock to provide care, compassion and safety to others.

As the number of confirmed cases and deaths attributed to COVID-19 continue to climb worldwide, policymakers should act quickly to respond. As state policymakers take steps to ensure that their communities are prepared for COVID-19, they should evaluate their state’s laws and emergency plans to ensure that pharmacists practicing in hospitals, clinics, physician offices, and retail settings are able to effectively support the COVID-19 response. In many communities, pharmacists are the most accessible healthcare providers and the first touchpoint of patient engagement with the healthcare system. In fact, 90% of all Americans live within five miles of a community pharmacy. In rural and underserved communities and in areas experiencing physician shortages, pharmacists may be the only healthcare provider that is immediately accessible to patients. Pharmacists practicing in hospitals, clinics, physician offices, and community settings are trained to treat infectious diseases and can significantly expand access to care, if barriers are removed. Pharmacists receive a clinically based doctor of pharmacy degree, and many also complete postgraduate residencies and become board certified in areas of specialty care, including infectious disease. Each year, nearly 4,000 pharmacists complete a pharmacy residency and 1,300 complete an additional residency in a clinical specialty. There are currently more than 800 board-certified infectious disease pharmacists nationwide. Forty-nine states and the District of Columbia grant pharmacists the ability to practice collaboratively with physicians.





20 views

Tel: 888-442-8349

Not available to UT, VT or WA residents

Not Available to UT, VT or WA Residents

CORPORATE HOURS

Monday - Friday:  9:00 AM to 5:00 PM

Saturday & Sunday: Closed

Info@AlereRx.com

PSGA, Inc

520 S. PARK AVE, SUITE B

WINTER PARK, FL 32789 

Tel: 888-442-8348

Proud member of:

  • Facebook
  • Twitter
  • Instagram

DISCLOSURES

This discount card program is NOT insurance, not intended to replace insurance, and does not meet the minimum creditable coverage requirements under the Affordable Care Act or Massachusetts M.G.L. c. 111M and 956 CRM 5.00. It contains a 30-day cancellation period, provides discounts only at the offices of contracted health care providers, and each member is obligated to pay the discounted medical charges in full at the point of service. For a complete list of disclosures, please click here. | Limitations, Exclusions and Exceptions | Discount Plan Organization: New Benefits, Ltd., Attn: Compliance Department, PO Box 803475, Dallas, TX 75380-3475.

© 2019 Teladoc, Inc. All rights reserved. Teladoc and the Teladoc logo are registered trademarks of Teladoc, Inc. and may not be used without written permission. Teladoc does not replace the primary care physician. Teladoc does not guarantee that a prescription will be written. Teladoc operates subject to state regulation and may not be available in certain states. Teladoc does not prescribe DEA controlled substances, non-therapeutic drugs and certain other drugs which may be harmful because of their potential for abuse. Teladoc physicians reserve the right to deny care for potential misuse of services

© 2020 AlereRx All Rights Reserved